Cytokine-induced increases in endothelial permeability occur after adhesion molecule expression

Surgery. 1996 Aug;120(2):411-6; discussion 416-7. doi: 10.1016/s0039-6060(96)80317-5.

Abstract

Background: Transmigration of neutrophils (PMNs) through endothelial cell tight junctions is a critical stage in the tissue injury of ischemia-reperfusion (I/R). Although cytokines are released in I/R, it is unclear whether cytokines directly increase permeability or this phenomenon requires both expression of cell adhesion molecules and PMN adhesion-activation.

Methods: We exposed confluent monolayers of human umbilical vein endothelial cells to physiologic concentrations of interleukin-1 (10 pg/ml) and tumor necrosis factor-alpha (10 pg/ml) in the absence of PMNs. Tight junction permeability was quantified with both transendothelial electrical resistance and albumin flux, whereas expression of endothelial-leukocyte adhesion molecule-1 was measured by flow cytometry (t test p < 0.05).

Results: Stimulation with tumor necrosis factor-alpha or interleukin-1 produced maximal transendothelial electrical resistance decreases at 12 hours with return to baseline at 24 hours. Increases in albumin flux began at 6 hours, with maximum effects at 24 hours. These changes occurred soon after maximal expression of endothelial-leukocyte adhesion molecule-1 at 4 hours.

Conclusions: Cytokines induced increases in both cell adhesion molecule expression and endothelial permeability. This sequence of events is consistent with direct cytokine effects on cytoarchitecture, because it occurred without the adhesion-activation of PMNs.

MeSH terms

  • Albumins / pharmacokinetics*
  • Cell Membrane Permeability / drug effects*
  • Cell Membrane Permeability / physiology
  • Cells, Cultured / metabolism
  • Cytochalasin D / pharmacology
  • E-Selectin / biosynthesis*
  • Electric Impedance
  • Endothelium, Vascular / cytology*
  • Humans
  • Interleukin-1 / pharmacology*
  • Tight Junctions / drug effects
  • Tight Junctions / physiology
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Umbilical Veins / cytology

Substances

  • Albumins
  • E-Selectin
  • Interleukin-1
  • Tumor Necrosis Factor-alpha
  • Cytochalasin D